Related references
Note: Only part of the references are listed.Variation of circulating tumor cell levels during treatment of metastatic breast cancer:: prognostic and therapeutic implications
F. Nole et al.
ANNALS OF ONCOLOGY (2008)
Heterogeneity of breast cancer metastases: Comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases
Julie M. Wu et al.
CLINICAL CANCER RESEARCH (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
Is there a role for positron emission tomography in breast cancer staging?
Nicole C. Hodgson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures
David Fuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse
Katharina Pachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C. Pestalozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bone metastases in patients with metastatic breast cancer: Morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT
Ukihide Tateishi et al.
RADIOLOGY (2008)
Fusion of metabolic function and morphology:: Sequential [18F] fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer
Yong Du et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden
Massimo Cristofanilli et al.
CLINICAL BREAST CANCER (2007)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
Brigette B. Y. Ma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency
Mika Suzuki et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis
JJ Gaforio et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography - Clinical use, interpretation methods, diagnostic improvements
C Cohade et al.
SEMINARS IN NUCLEAR MEDICINE (2003)
Whole body PET for the evaluation of bony metastases in patients with breast cancer:: comparison with 99Tcm-MDP bone scintigraphy
M Ohta et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
EF Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
